Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Biocryst Pharmaceuticals (BCRX) Q2 2026 Earnings
BCRX
6
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-2.98
-1.97
-0.95
0.06
Details
Expected EPS
0.044267
Actual EPS
-2.98
Surprise EPS
-3.02
Surprise Percent
+6,831.88%
Description
Biocryst Pharmaceuticals (BCRX) has reported earnings of -2.98 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login